<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00912990</url>
  </required_header>
  <id_info>
    <org_study_id>11672</org_study_id>
    <secondary_id>06104C</secondary_id>
    <nct_id>NCT00912990</nct_id>
  </id_info>
  <brief_title>Pediatric Elective Intubation With and Without Muscle Relaxation Utilizing the Shikani Optical Stylet</brief_title>
  <official_title>Pediatric Elective Intubation With and Without Muscle Relaxation Utilizing the Shikani Optical Stylet</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rady Children's Hospital, San Diego</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rady Children's Hospital, San Diego</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators' primary specific aims are to demonstrate that:&#xD;
&#xD;
        1. Pediatric patients with normal airways, undergoing elective surgical procedures, can be&#xD;
           successfully intubated when deeply sedated, without the use of muscle relaxants using&#xD;
           the Shikani Optical Stylet.&#xD;
&#xD;
        2. Shikani intubation of pediatric patients is equally effective in children that are&#xD;
           deeply sedated or paralyzed as evidenced by a non-significant difference in:&#xD;
&#xD;
             -  Time to intubation (defined as no more than a 30 second time difference between the&#xD;
                two groups);&#xD;
&#xD;
             -  Incidence of adverse events.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Adequate subjects numbers not enrolled in study timeframe.&#xD;
  </why_stopped>
  <start_date>January 2007</start_date>
  <completion_date type="Actual">February 2008</completion_date>
  <primary_completion_date type="Actual">February 2008</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to Intubation</measure>
    <time_frame>Confirmed by the visualization of three carbon dioxide waveforms.</time_frame>
    <description>Time to intubation was defined as the time (seconds) required to verify three breaths on an end-tidal carbon dioxide monitor.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The Number of Adverse Events</measure>
    <time_frame>Recorded from the start of the intubation procedure to the time of successful endotracheal intubation</time_frame>
    <description>The number of occurrences of each event. One subject may have multiple adverse events.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Number of Intubation Attempts for Each Enrolled Subject</measure>
    <time_frame>The number is totaled after successful endotracheal intubation is documented</time_frame>
    <description>The total number of intubation attempts to achieve successful intubation of study participants.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">34</enrollment>
  <condition>Intubation,Endotracheal</condition>
  <arm_group>
    <arm_group_label>Normal saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Normal saline volume calculated to be equal to the volume of cisatracurium 0.2mg/kg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Cisatracurium</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects in this arm will be given Cisatracurium 0.2mg/kg IV dose one time prior to intubation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cisatracurium</intervention_name>
    <description>One intravenous dose: 0.2mg/kg/dose</description>
    <arm_group_label>Cisatracurium</arm_group_label>
    <other_name>Nimbex</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal saline</intervention_name>
    <description>One Intravenous dose</description>
    <arm_group_label>Normal saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  6 months of age to 17 years of age (not yet 18)&#xD;
&#xD;
          -  Male or female&#xD;
&#xD;
          -  English or Spanish speaking&#xD;
&#xD;
          -  Normal airway (Mallampati Classification )&#xD;
&#xD;
          -  American Society of Anesthesiology Physical Status Classification I or II&#xD;
&#xD;
          -  Elective surgical procedure expected to last at least 45 minutes in length&#xD;
&#xD;
          -  Written informed consent/assent for participation given by the parent legal guardian&#xD;
             and subject (if applicable)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  &lt; 6 months of age, &gt; 17 years of age&#xD;
&#xD;
          -  Difficult airway (Mallampati Classification)&#xD;
&#xD;
          -  History of previous difficult intubation, suspected abnormal airway: *micrognathia&#xD;
&#xD;
               -  facial trauma&#xD;
&#xD;
               -  airway tumor&#xD;
&#xD;
               -  epiglottitis&#xD;
&#xD;
               -  retropharyngeal abscess&#xD;
&#xD;
               -  foreign body, etc.&#xD;
&#xD;
               -  Scheduled for non-elective, emergent OR procedure&#xD;
&#xD;
               -  Parent, legal guardian, or subject is unavailable or unwilling to consent for&#xD;
                  study participation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Rady Children's Hospital</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92123</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>June 1, 2009</study_first_submitted>
  <study_first_submitted_qc>June 1, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 3, 2009</study_first_posted>
  <results_first_submitted>July 23, 2012</results_first_submitted>
  <results_first_submitted_qc>August 10, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">August 12, 2020</results_first_posted>
  <last_update_submitted>August 11, 2020</last_update_submitted>
  <last_update_submitted_qc>August 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rady Children's Hospital, San Diego</investigator_affiliation>
    <investigator_full_name>Sandeep Khanna</investigator_full_name>
    <investigator_title>Attending Physician Division of Pediatric Critical Care</investigator_title>
  </responsible_party>
  <keyword>Pediatric</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cisatracurium</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Subjects were screened and enrolled at a single, pediatric hospital site.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Cisatracurium</title>
          <description>Subjects in this arm will be given Cisatracurium 0.2mg/kg IV dose one time prior to intubation.&#xD;
Cisatracurium : One intravenous dose: 0.2mg/kg/dose</description>
        </group>
        <group group_id="P2">
          <title>Normal Saline</title>
          <description>Normal saline volume calculated to be equal to the volume of cisatracurium 0.2mg/kg&#xD;
Normal saline : One Intravenous dose</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
                <participants group_id="P2" count="18"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
                <participants group_id="P2" count="18"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Cisatracurium</title>
          <description>Subjects in this arm will be given Cisatracurium 0.2mg/kg IV dose one time prior to intubation.&#xD;
Cisatracurium : One intravenous dose: 0.2mg/kg/dose</description>
        </group>
        <group group_id="B2">
          <title>Normal Saline</title>
          <description>Normal saline volume calculated to be equal to the volume of cisatracurium 0.2mg/kg&#xD;
Normal saline : One Intravenous dose</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="16"/>
            <count group_id="B2" value="18"/>
            <count group_id="B3" value="34"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="34"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Time to Intubation</title>
        <description>Time to intubation was defined as the time (seconds) required to verify three breaths on an end-tidal carbon dioxide monitor.</description>
        <time_frame>Confirmed by the visualization of three carbon dioxide waveforms.</time_frame>
        <population>Unable to summarize data or complete analysis due to small study sample and technical problems with measurement leading to unreliable data.</population>
        <group_list>
          <group group_id="O1">
            <title>Cisatracurium</title>
            <description>Subjects in this arm will be given Cisatracurium 0.2mg/kg IV dose one time prior to intubation.&#xD;
Cisatracurium : One intravenous dose: 0.2mg/kg/dose</description>
          </group>
          <group group_id="O2">
            <title>Normal Saline</title>
            <description>Normal saline volume calculated to be equal to the volume of cisatracurium 0.2mg/kg&#xD;
Normal saline : One Intravenous dose</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Intubation</title>
          <description>Time to intubation was defined as the time (seconds) required to verify three breaths on an end-tidal carbon dioxide monitor.</description>
          <population>Unable to summarize data or complete analysis due to small study sample and technical problems with measurement leading to unreliable data.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Number of Adverse Events</title>
        <description>The number of occurrences of each event. One subject may have multiple adverse events.</description>
        <time_frame>Recorded from the start of the intubation procedure to the time of successful endotracheal intubation</time_frame>
        <population>No further statistical analysis (intent-to-treat) completed due to small study sample.</population>
        <group_list>
          <group group_id="O1">
            <title>Cisatracurium</title>
            <description>Subjects in this arm will be given Cisatracurium 0.2mg/kg IV dose one time prior to intubation.&#xD;
Cisatracurium : One intravenous dose: 0.2mg/kg/dose</description>
          </group>
          <group group_id="O2">
            <title>Normal Saline</title>
            <description>Normal saline volume calculated to be equal to the volume of cisatracurium 0.2mg/kg&#xD;
Normal saline : One Intravenous dose</description>
          </group>
        </group_list>
        <measure>
          <title>The Number of Adverse Events</title>
          <description>The number of occurrences of each event. One subject may have multiple adverse events.</description>
          <population>No further statistical analysis (intent-to-treat) completed due to small study sample.</population>
          <units>events</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
                <count group_id="O2" value="18"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Number of Intubation Attempts for Each Enrolled Subject</title>
        <description>The total number of intubation attempts to achieve successful intubation of study participants.</description>
        <time_frame>The number is totaled after successful endotracheal intubation is documented</time_frame>
        <population>Unable to analyze data due to small study sample.</population>
        <group_list>
          <group group_id="O1">
            <title>Cisatracurium</title>
            <description>Subjects in this arm will be given Cisatracurium 0.2mg/kg IV dose one time prior to intubation.&#xD;
Cisatracurium : One intravenous dose: 0.2mg/kg/dose</description>
          </group>
          <group group_id="O2">
            <title>Normal Saline</title>
            <description>Normal saline volume calculated to be equal to the volume of cisatracurium 0.2mg/kg&#xD;
Normal saline : One Intravenous dose</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Intubation Attempts for Each Enrolled Subject</title>
          <description>The total number of intubation attempts to achieve successful intubation of study participants.</description>
          <population>Unable to analyze data due to small study sample.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Cisatracurium</title>
          <description>Subjects in this arm will be given Cisatracurium 0.2mg/kg IV dose one time prior to intubation.&#xD;
Cisatracurium : One intravenous dose: 0.2mg/kg/dose</description>
        </group>
        <group group_id="E2">
          <title>Normal Saline</title>
          <description>Normal saline volume calculated to be equal to the volume of cisatracurium 0.2mg/kg&#xD;
Normal saline : One Intravenous dose</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="18"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="18"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Laryngospasm</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="18"/>
              </event>
              <event>
                <sub_title>Participant movement/cough/gag</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="18"/>
              </event>
              <event>
                <sub_title>Esophageal intubation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="18"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Inadequate subject numbers led to early termination. Unable to adequately power the study for data analysis. OAE data reported for transparency only and should not be used to extrapolate significant conclusions.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Sandeep Khanna</name_or_title>
      <organization>Rady Children's Hospital San Diego</organization>
      <phone>858-966-5863</phone>
    </point_of_contact>
  </clinical_results>
</clinical_study>

